Ncardia develops a wide range of in-vitro cell models from human induced pluripotent stem cells. These cell models are used for research into the safety and effectiveness of drugs and as the basis of cell therapy.

Ncardia is using Mibiton funding to purchase an ImageXpress Micro Confocal High-Content Imaging System, which can measure a wide range of cellular phenotypes.